Von Willebrand disease natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
There is physiologic rise in [[von Willebrand factor]] levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.<ref name="pmid25756206">{{cite journal |vauthors=Rydz N, Grabell J, Lillicrap D, James PD |title=Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease |journal=Haemophilia |volume=21 |issue=5 |pages=636–41 |year=2015 |pmid=25756206 |pmc=4678413 |doi=10.1111/hae.12664 |url=}}</ref> However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age<ref name="pmid24750783">{{cite journal |vauthors=Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW |title=von Willebrand disease and aging: an evolving phenotype |journal=J. Thromb. Haemost. |volume=12 |issue=7 |pages=1066–75 |year=2014 |pmid=24750783 |doi=10.1111/jth.12586 |url=}}</ref> Menorrhagia is a major complication, which also impairs the quality of life.<ref name="pmid20584085">{{cite journal |vauthors=Kadir RA, Edlund M, Von Mackensen S |title=The impact of menstrual disorders on quality of life in women with inherited bleeding disorders |journal=Haemophilia |volume=16 |issue=5 |pages=832–9 |year=2010 |pmid=20584085 |doi=10.1111/j.1365-2516.2010.02269.x |url=}}</ref> Angiodysplasia is serious, and possibly life-threatening complication.<ref name="pmid25381842">{{cite journal |vauthors=Makris M, Federici AB, Mannucci PM, Bolton-Maggs PH, Yee TT, Abshire T, Berntorp E |title=The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease |journal=Haemophilia |volume=21 |issue=3 |pages=338–42 |year=2015 |pmid=25381842 |doi=10.1111/hae.12571 |url=}}</ref> Intraarticular bleeding (although rare) may be a presenting symptom in those with type 2N or type 3 disease.<ref name="pmid23010260">{{cite journal |vauthors=van Galen KP, Mauser-Bunschoten EP, Leebeek FW |title=Hemophilic arthropathy in patients with von Willebrand disease |journal=Blood Rev. |volume=26 |issue=6 |pages=261–6 |year=2012 |pmid=23010260 |doi=10.1016/j.blre.2012.09.002 |url=}}</ref> Primary and secondary postpartum bleeding is a commmon complication.<ref name="pmid26164463">{{cite journal |vauthors=Kouides PA |title=An update on the management of bleeding disorders during pregnancy |journal=Curr. Opin. Hematol. |volume=22 |issue=5 |pages=397–405 |year=2015 |pmid=26164463 |doi=10.1097/MOH.0000000000000167 |url=}}</ref><ref name="pmid21947221">{{cite journal |vauthors=De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW |title=Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease |journal=Thromb. Haemost. |volume=106 |issue=5 |pages=885–92 |year=2011 |pmid=21947221 |doi=10.1160/TH11-03-0180 |url=}}</ref><ref name="pmid25688733">{{cite journal |vauthors=Stoof SC, van Steenbergen HW, Zwagemaker A, Sanders YV, Cannegieter SC, Duvekot JJ, Leebeek FW, Peters M, Kruip MJ, Eikenboom J |title=Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey |journal=Haemophilia |volume=21 |issue=4 |pages=505–12 |year=2015 |pmid=25688733 |doi=10.1111/hae.12635 |url=}}</ref>
There is physiologic rise in [[von Willebrand factor]] levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.<ref name="pmid25756206">{{cite journal |vauthors=Rydz N, Grabell J, Lillicrap D, James PD |title=Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease |journal=Haemophilia |volume=21 |issue=5 |pages=636–41 |year=2015 |pmid=25756206 |pmc=4678413 |doi=10.1111/hae.12664 |url=}}</ref> However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age<ref name="pmid24750783">{{cite journal |vauthors=Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW |title=von Willebrand disease and aging: an evolving phenotype |journal=J. Thromb. Haemost. |volume=12 |issue=7 |pages=1066–75 |year=2014 |pmid=24750783 |doi=10.1111/jth.12586 |url=}}</ref> Menorrhagia is a major complication, which also impairs the quality of life.<ref name="pmid20584085">{{cite journal |vauthors=Kadir RA, Edlund M, Von Mackensen S |title=The impact of menstrual disorders on quality of life in women with inherited bleeding disorders |journal=Haemophilia |volume=16 |issue=5 |pages=832–9 |year=2010 |pmid=20584085 |doi=10.1111/j.1365-2516.2010.02269.x |url=}}</ref> Angiodysplasia is serious, and possibly life-threatening complication.<ref name="pmid25381842">{{cite journal |vauthors=Makris M, Federici AB, Mannucci PM, Bolton-Maggs PH, Yee TT, Abshire T, Berntorp E |title=The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease |journal=Haemophilia |volume=21 |issue=3 |pages=338–42 |year=2015 |pmid=25381842 |doi=10.1111/hae.12571 |url=}}</ref> Intraarticular bleeding (although rare) may be a presenting symptom in those with type 2N or type 3 disease.<ref name="pmid23010260">{{cite journal |vauthors=van Galen KP, Mauser-Bunschoten EP, Leebeek FW |title=Hemophilic arthropathy in patients with von Willebrand disease |journal=Blood Rev. |volume=26 |issue=6 |pages=261–6 |year=2012 |pmid=23010260 |doi=10.1016/j.blre.2012.09.002 |url=}}</ref> Primary and secondary postpartum bleeding is a commmon complication.<ref name="pmid26164463">{{cite journal |vauthors=Kouides PA |title=An update on the management of bleeding disorders during pregnancy |journal=Curr. Opin. Hematol. |volume=22 |issue=5 |pages=397–405 |year=2015 |pmid=26164463 |doi=10.1097/MOH.0000000000000167 |url=}}</ref><ref name="pmid21947221">{{cite journal |vauthors=De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW |title=Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease |journal=Thromb. Haemost. |volume=106 |issue=5 |pages=885–92 |year=2011 |pmid=21947221 |doi=10.1160/TH11-03-0180 |url=}}</ref><ref name="pmid25688733">{{cite journal |vauthors=Stoof SC, van Steenbergen HW, Zwagemaker A, Sanders YV, Cannegieter SC, Duvekot JJ, Leebeek FW, Peters M, Kruip MJ, Eikenboom J |title=Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey |journal=Haemophilia |volume=21 |issue=4 |pages=505–12 |year=2015 |pmid=25688733 |doi=10.1111/hae.12635 |url=}}</ref>


==Natural history, complications and prognosis==
==Natural history, Complications and Prognosis==
 
=== Natural History ===
 
=== Complications ===
 
=== prognosis ===
*Patients with von willebrand disease have a lower health-related quality of life compared to the general population especially with the bleeding phenotype.<ref name="pmid20345712">{{cite journal |vauthors=de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW |title=Health-related quality of life among adult patients with moderate and severe von Willebrand disease |journal=J. Thromb. Haemost. |volume=8 |issue=7 |pages=1492–9 |year=2010 |pmid=20345712 |doi=10.1111/j.1538-7836.2010.03864.x |url=}}</ref>
*Patients with von willebrand disease have a lower health-related quality of life compared to the general population especially with the bleeding phenotype.<ref name="pmid20345712">{{cite journal |vauthors=de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW |title=Health-related quality of life among adult patients with moderate and severe von Willebrand disease |journal=J. Thromb. Haemost. |volume=8 |issue=7 |pages=1492–9 |year=2010 |pmid=20345712 |doi=10.1111/j.1538-7836.2010.03864.x |url=}}</ref>
*There is physiologic rise in von Willebrand factor levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.<ref name="pmid25756206">{{cite journal |vauthors=Rydz N, Grabell J, Lillicrap D, James PD |title=Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease |journal=Haemophilia |volume=21 |issue=5 |pages=636–41 |year=2015 |pmid=25756206 |pmc=4678413 |doi=10.1111/hae.12664 |url=}}</ref> However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age<ref name="pmid24750783">{{cite journal |vauthors=Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW |title=von Willebrand disease and aging: an evolving phenotype |journal=J. Thromb. Haemost. |volume=12 |issue=7 |pages=1066–75 |year=2014 |pmid=24750783 |doi=10.1111/jth.12586 |url=}}</ref>
*There is physiologic rise in von Willebrand factor levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.<ref name="pmid25756206">{{cite journal |vauthors=Rydz N, Grabell J, Lillicrap D, James PD |title=Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease |journal=Haemophilia |volume=21 |issue=5 |pages=636–41 |year=2015 |pmid=25756206 |pmc=4678413 |doi=10.1111/hae.12664 |url=}}</ref> However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age<ref name="pmid24750783">{{cite journal |vauthors=Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW |title=von Willebrand disease and aging: an evolving phenotype |journal=J. Thromb. Haemost. |volume=12 |issue=7 |pages=1066–75 |year=2014 |pmid=24750783 |doi=10.1111/jth.12586 |url=}}</ref>

Revision as of 15:02, 30 August 2018

Von Willebrand disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Von Willebrand disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Von Willebrand disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Von Willebrand disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Von Willebrand disease natural history, complications and prognosis

on Von Willebrand disease natural history, complications and prognosis

Von Willebrand disease natural history, complications and prognosis in the news

Blogs on Von Willebrand disease natural history, complications and prognosis

Directions to Hospitals Treating Von Willebrand disease

Risk calculators and risk factors for Von Willebrand disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Patients with von willebrand disease have a lower health-related quality of life compared to the general population especially with the bleeding phenotype.[1] There is physiologic rise in von Willebrand factor levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.[2] However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age[3] Menorrhagia is a major complication, which also impairs the quality of life.[4] Angiodysplasia is serious, and possibly life-threatening complication.[5] Intraarticular bleeding (although rare) may be a presenting symptom in those with type 2N or type 3 disease.[6] Primary and secondary postpartum bleeding is a commmon complication.[7][8][9]

Natural history, Complications and Prognosis

Natural History

Complications

prognosis

  • Patients with von willebrand disease have a lower health-related quality of life compared to the general population especially with the bleeding phenotype.[1]
  • There is physiologic rise in von Willebrand factor levels throughout life. As a result of this, patients with type 1 von Willebrand’s disease may have normal levels of vWF at older age.[2] However, bleeding symptoms occur at similar frequency in patients older than 65 years as well as in those who are 18 to 65 years of age[3]
  • Menorrhagia is a major complication, which also impairs the quality of life.[4]
  • Angiodysplasia is serious, and possibly life-threatening complication.[5]
  • Intraarticular bleeding (although rare) may be a presenting symptom in those with type 2N or type 3 disease.[6]
  • Primary and secondary postpartum bleeding is a commmon complication.[7][8][9]

References

  1. 1.0 1.1 de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW (2010). "Health-related quality of life among adult patients with moderate and severe von Willebrand disease". J. Thromb. Haemost. 8 (7): 1492–9. doi:10.1111/j.1538-7836.2010.03864.x. PMID 20345712.
  2. 2.0 2.1 Rydz N, Grabell J, Lillicrap D, James PD (2015). "Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease". Haemophilia. 21 (5): 636–41. doi:10.1111/hae.12664. PMC 4678413. PMID 25756206.
  3. 3.0 3.1 Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW (2014). "von Willebrand disease and aging: an evolving phenotype". J. Thromb. Haemost. 12 (7): 1066–75. doi:10.1111/jth.12586. PMID 24750783.
  4. 4.0 4.1 Kadir RA, Edlund M, Von Mackensen S (2010). "The impact of menstrual disorders on quality of life in women with inherited bleeding disorders". Haemophilia. 16 (5): 832–9. doi:10.1111/j.1365-2516.2010.02269.x. PMID 20584085.
  5. 5.0 5.1 Makris M, Federici AB, Mannucci PM, Bolton-Maggs PH, Yee TT, Abshire T, Berntorp E (2015). "The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease". Haemophilia. 21 (3): 338–42. doi:10.1111/hae.12571. PMID 25381842.
  6. 6.0 6.1 van Galen KP, Mauser-Bunschoten EP, Leebeek FW (2012). "Hemophilic arthropathy in patients with von Willebrand disease". Blood Rev. 26 (6): 261–6. doi:10.1016/j.blre.2012.09.002. PMID 23010260.
  7. 7.0 7.1 Kouides PA (2015). "An update on the management of bleeding disorders during pregnancy". Curr. Opin. Hematol. 22 (5): 397–405. doi:10.1097/MOH.0000000000000167. PMID 26164463.
  8. 8.0 8.1 De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW (2011). "Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease". Thromb. Haemost. 106 (5): 885–92. doi:10.1160/TH11-03-0180. PMID 21947221.
  9. 9.0 9.1 Stoof SC, van Steenbergen HW, Zwagemaker A, Sanders YV, Cannegieter SC, Duvekot JJ, Leebeek FW, Peters M, Kruip MJ, Eikenboom J (2015). "Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey". Haemophilia. 21 (4): 505–12. doi:10.1111/hae.12635. PMID 25688733.

Template:WH Template:WS